Immunogenic Display of Diverse Peptides on Virus-like Particles of RNA Phage MS2
- 1 June 2008
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 380 (1) , 252-263
- https://doi.org/10.1016/j.jmb.2008.04.049
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 AI065240, 5RO1 GM042901)
This publication has 62 references indexed in Scilit:
- Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid TumorsJournal of Clinical Oncology, 2012
- The PI3K Pathway As Drug Target in Human CancerJournal of Clinical Oncology, 2010
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009
- Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for ResistanceCancer Research, 2008
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancersNature Medicine, 2008
- Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235Cancer Research, 2008
- NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K MutationsCancer Research, 2008
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006
- The Refined Structure of Bacteriophage MS2 at 2·8 Å ResolutionJournal of Molecular Biology, 1993
- Thermal stability of hemoglobin crosslinked in the T-state by bis(3,5-dibromosalicyl) fumarateBiochemical and Biophysical Research Communications, 1991